NYSE:CLB Core Laboratories (CLB) Stock Price, News & Analysis $13.48 +0.03 (+0.22%) As of 01:28 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Core Laboratories Stock (NYSE:CLB) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Core Laboratories alerts:Sign Up Key Stats Today's Range$13.11▼$13.5750-Day Range$13.44▼$17.6152-Week Range$9.72▼$20.36Volume177,979 shsAverage Volume410,954 shsMarket Capitalization$621.43 millionP/E Ratio20.78Dividend Yield0.30%Price Target$12.50Consensus RatingHold Company Overview Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets. The company’s portfolio spans two primary service lines: reservoir description and production enhancement. In reservoir description, Core Laboratories performs detailed analyses on drill-cuttings, cores and reservoir fluids to characterize rock and fluid properties. Under production enhancement, the company offers well stimulation, downhole chemistry, and scale and corrosion management solutions designed to improve flow rates and mitigate operational risks. These services are supported by a global network of research laboratories and field service centers equipped with advanced instrumentation. Headquartered in Amsterdam with key operating offices in Houston, Core Laboratories conducts business in more than 50 countries across six continents, serving major international and national oil companies, as well as independents. The company’s engineering and technical teams collaborate closely with clients to tailor solutions to diverse reservoir environments. Under the leadership of President and CEO Clay C. Williams, Core Laboratories continues to invest in innovation and technology development to address evolving challenges in reservoir management and production optimization.AI Generated. May Contain Errors. Read More Core Laboratories Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks35th Percentile Overall ScoreCLB MarketRank™: Core Laboratories scored higher than 35% of companies evaluated by MarketBeat, and ranked 192nd out of 248 stocks in the energy sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.2 / 5Analyst RatingHold Consensus RatingCore Laboratories has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 4 hold ratings, and no sell ratings.Downside RiskCore Laboratories has a consensus price target of $12.50, representing about 5.6% downside from its current price of $13.24.Amount of Analyst CoverageCore Laboratories has only been the subject of 1 research reports in the past 90 days.Read more about Core Laboratories' stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth45.61% Earnings GrowthEarnings for Core Laboratories are expected to grow by 45.61% in the coming year, from $0.57 to $0.83 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Core Laboratories is 20.60, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.38.Price to Earnings Ratio vs. SectorThe P/E ratio of Core Laboratories is 20.60, which means that it is trading at a more expensive P/E ratio than the Energy sector average P/E ratio of about 15.22.Price to Earnings Growth RatioCore Laboratories has a PEG Ratio of 2.57. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioCore Laboratories has a P/B Ratio of 2.22. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for CLB. Dividend1.7 / 5Dividend StrengthWeak Dividend YieldCore Laboratories has a dividend yield of 0.29%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthCore Laboratories does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Core Laboratories is 6.15%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Core Laboratories will have a dividend payout ratio of 4.82% next year. This indicates that Core Laboratories will be able to sustain or increase its dividend.Read more about Core Laboratories' dividend. News and Social Media2.7 / 5News Sentiment0.36 News SentimentCore Laboratories has a news sentiment score of 0.36. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.67 average news sentiment score of Energy companies.News Coverage This WeekMarketBeat has tracked 6 news articles for Core Laboratories this week, compared to 1 article on an average week.Search Interest1 people have searched for CLB on MarketBeat in the last 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Core Laboratories insiders have not sold or bought any company stock.Percentage Held by Insiders1.26% of the stock of Core Laboratories is held by insiders.Percentage Held by Institutions97.81% of the stock of Core Laboratories is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Core Laboratories' insider trading history. Receive CLB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Core Laboratories and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CLB Stock News HeadlinesCore Laboratories Earnings Call: Tech Strengths Amid TurmoilMay 6 at 8:56 AM | theglobeandmail.com5 Insightful Analyst Questions From Core Laboratories’s Q1 Earnings CallMay 6 at 8:56 AM | msn.comLouis Navellier: “I'm dropping everything on May 13.” Here's why.47-year Wall Street veteran Louis Navellier says a rare market pattern is forming for only the fifth time in his career - each previous instance was triggered by a Federal Reserve shift and preceded gains of 1,100% to 2,900% in select small-cap stocks. On May 13 at 1 p.m. ET, Navellier is hosting the 10X Fed Shock Summit to walk through what he sees unfolding before the new Fed Chair takes over on May 15. Sign up and receive his 53-stock 'Exclusion List' free, plus his single highest-conviction pick named live.May 8 at 1:00 AM | Stansberry Research (Ad)Top 3 Energy Stocks That May Jump In Q2May 4, 2026 | benzinga.comCore Laboratories (NYSE:CLB) Shares Down 6.7% - Here's What HappenedMay 3, 2026 | americanbankingnews.comWhy Core Laboratories (CLB) shares are sliding todayMay 2, 2026 | msn.comCLB Q1 deep dive: Geopolitical uncertainty and weather disruptions pressure marginsApril 30, 2026 | msn.comCore Laboratories Inc. (CLB) Q1 2026 Earnings Call TranscriptApril 30, 2026 | seekingalpha.comSee More Headlines CLB Stock Analysis - Frequently Asked Questions How have CLB shares performed this year? Core Laboratories' stock was trading at $16.02 at the beginning of 2026. Since then, CLB shares have decreased by 16.2% and is now trading at $13.42. How were Core Laboratories' earnings last quarter? Core Laboratories Inc. (NYSE:CLB) posted its quarterly earnings data on Wednesday, April, 29th. The oil and gas company reported $0.06 EPS for the quarter, hitting analysts' consensus estimates of $0.06. The firm's revenue was down 1.4% compared to the same quarter last year. Read the conference call transcript. Who are Core Laboratories' major shareholders? Core Laboratories' top institutional shareholders include Dimensional Fund Advisors LP (2.93%), Bank of New York Mellon Corp (0.88%), Principal Financial Group Inc. (0.59%) and Heartland Advisors Inc. (0.33%). View institutional ownership trends. How do I buy shares of Core Laboratories? Shares of CLB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Core Laboratories own? Based on aggregate information from My MarketBeat watchlists, some other companies that Core Laboratories investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), AUO (AUOTY) and DiamondRock Hospitality (DRH). Company Calendar Ex-Dividend for 3/9 Dividend2/13/2026Record date for 3/9 Dividend2/16/2026Dividend Payable3/09/2026Last Earnings4/29/2026Today5/08/2026Record date for 6/1 Dividend5/11/2026Ex-Dividend for 6/1 Dividend5/11/2026Dividend Payable6/01/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (1w+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 For the last 8 days, CLB's financial health has been in the Yellow zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNYSE SectorEnergy Industry OIL - FIELD SVCS Sub-IndustryPetroleum And Natural Gas Current SymbolNYSE:CLB CIK1958086 Webwww.corelab.com Phone(713) 328-2673FaxN/AEmployees3,300Year Founded1936Price Target and Rating Average Price Target for Core Laboratories$12.50 High Price Target$13.00 Low Price Target$12.00 Potential Upside/Downside-7.1%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage4 Analysts Profitability EPS (Trailing Twelve Months)$0.65 Trailing P/E Ratio20.71 Forward P/E Ratio23.61 P/E Growth2.57Net Income$29.67 million Net Margins5.94% Pretax Margin8.21% Return on Equity11.52% Return on Assets5.32% Debt Debt-to-Equity Ratio0.42 Current Ratio2.05 Quick Ratio1.50 Sales & Book Value Annual Sales$526.52 million Price / Sales1.18 Cash Flow$1.05 per share Price / Cash Flow12.80 Book Value$5.97 per share Price / Book2.25Miscellaneous Outstanding Shares46,100,000Free Float45,516,000Market Cap$620.51 million OptionableOptionable Beta0.99 Social Links 7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (NYSE:CLB) was last updated on 5/8/2026 by MarketBeat.com Staff. From Our PartnersOne executive order. The biggest wealth transfer of your lifetime.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredMassive Data Leak Exposes 512,000-Line Code That Could Change Society Forever"You won't believe what I discovered at 4 World Trade Center" When our financial media correspondent travel...Chaikin Analytics | Sponsored"Computers are about to become obsolete" - George Gilder. Here’s why.George Gilder predicted the iPhone 16 years early, called Netflix a decade before it dominated streaming, and ...Eagle Publishing | SponsoredI’m sounding the alarmMeta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, ...Porter & Company | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredMay 13: The Fed Shock is about to hit the marketsWall Street quantitative analyst Louis Navellier says a rare Federal Reserve regime change is opening a market...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Core Laboratories Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Core Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
